Medicalgorithmics Unveils New Growth Strategy through 2026
Medicalgorithmics has adopted a new growth strategy for 2023-2026 to strengthen its position as a global provider of non-invasive cardiac diagnostic technology. The company will focus on commercializing proprietary software for medical data analysis, AI/ML algorithms, and integrating software with third-party devices.